Board of Directors
Liang Lin Executive Chairman, Director
Liang Lin is the founder and CEO of Sol-Millennium Medical Group, dedicated to transforming the medical device sector. He launched the Sol-Millennium Medical project in Shanghai, driven by a commitment to a healthier future. His focus on innovation and patient safety has led to the development of advanced medical devices. Under his leadership, the company expanded into North America and Brazil through acquisitions of Inviro Medical Inc. and Medica Brazil, and established an EMEA office in Poland to address healthcare needs in Europe and the Middle East. Liang’s expertise and dedication have positioned Sol-Millennium as a leader in the industry.
Dr. John Leombruno Director
John Lemobruno has executive level experience in many areas of the pharmaceutical industry, including market access, medical information, pharmacovigilance, medical affairs, and business development. He co-founded Patient Direct (a patient support and specialty pharmacy provider) and GMD Distribution (a pharmaceutical distribution, patient support and specialty pharmacy services firm), both of which were acquired by McKesson Canada between 2010 and 2017. In 2019, John started OkRx, a Canadian Healthcare software company focusing on helping patients, prescribers, insurers, and pharmaceutical companies manage specialty medications. Dr. Leombruno is formally trained as a Pharmacist and has earned an MBA from Queen’s University and a PhD in Pharmacoepidemiology from University of Toronto.
Karen Dunlap Director
Karen Dunlap was President/COO, The Americas, UK, Europe and Board Director at Sol-Millennium Medical Group, from September 2011 – December 2019, responsible for acquisition of devices in order to launch into the US and overseeing markets to develop a strategic platform and establish a global sales/marketing team. She was a Sr. Vice President Business Development from March 2005 - September 2011 for Inviro Medical, and represented the company in many different roles and regions including Target Accounts US, Canada and Latin America. Prior to working with Inviro Medical, Ms. Dunlap was an independent consultant working with start-up emerging companies on product development and launch. Ms. Dunlap was Vice President Sales for NMT, partnering with Pharmaceutical Companies on specific medication delivery, and Regional Manager for Medfusion and Medex, focused in the Neonatal and Pediatric markets, where she has extensive experience in accurate medication delivery systems.
Philip Cortese Director
Mr. Cortese is a seasoned banker with over 30 years of experience in the financial institution industry and has held senior managerial positions at RBC, TD Bank and CIBC for over half of those years. In 2002, he was recruited by TD Bank to head the Quebec office of its real estate financing commercial mortgage-backed securities (CMBS) origination group as vice-president for the Quebec region. The CMBS group originated close to $1 billion of new commercial mortgages over a period of just 4 years. In October of 2012, he joined a local real estate investor, Kheng Ly, and together branded the development company now known as Brivia Group. Mr. Cortese is a former Canadian Securities Institute graduate and a licensed commercial real estate broker.
Kwun Loy Liu Director
Kwun Loy Liu has over 18 years of work experience in healthcare, investment and strategic consulting across Asia, Europe and North America. He is currently the Investment Vice President at Winner Medical and leading the strategic investment effort of the group. Prior to joining Winner Medical, Mr. Liu worked at McKinsey, Morgan Stanley, Bain Capital and Shenzhen Neptunus Group. Mr. Liu holds degrees in business administration and software engineering from The University of Hong Kong.
Louise Cresswell Director
Louise has extensive experience in the healthcare sector. Her career started in the NHS where she qualified as a Registered Nurse with an Ophthalmic Nursing Diploma working in accident and emergency departments. After qualifying as a midwife, she moved to Practice Nursing in the community, specialising in women’s health and family planning. Louise re-qualified as a Registered nurse in 2021. Louise’s commercial career began with Ethicon, J&J, as a sales representative progressing to regional manager and business development manager focusing on the clinical and commercial needs of the business to grow sales in wound closure products in both NHS and private hospital groups. A move to the role of sales director for BD Medical (UK) specialising in injection and infusion technologies progressed her commercial and management skills and leadership experience of both clinical, sales and marketing teams while managing national commercial tender agreements, local hospital pricing and supply agreements, achieving supply chain efficiencies for the supply of products into NHS Supply Chain warehouses through her leadership of a UK and European multi-disciplinary supply chain optimisation project. Louise also completed an MBA. Louise established her own consultancy company, Visea Ltd in 2006 and completed an MSc in Organisational Development and Management Learning. In the consultant role Louise has worked with medical technology start-up companies through to market-leading global companies from the US, Australia, Asia, UK and Europe providing project support and working in retained roles as UK Partner, Associate Director and Global Business Development Manager in the areas of market access, sales, business development and training. Projects have included product development, establishing UK business’, pricing and tendering, distributor management, recruitment, selection and management of sales and marketing teams, developing /delivering training and education to clinical and non-clinical stakeholders in a range of therapy and disease areas.
Arvind Rai Director
Arvind Rai has extensive experience in finance and audit, having held key positions in various companies and regions. Arvind is currently the Vice President of Global Finance at Sol-Millennium Medical Group, where Arvind established global finance and controller functions. Prior to this, Arvind served as the Chief Finance Officer and Corporate Controller at ArcelorMittal, where Arvind led innovative strategies and directed data analytics for compliance. Arvind also has experience in forensic services, managing teams and investigating fraud matters in multiple countries. With a strong educational background in accountancy, audit, and fraud examination, Arvind brings a wealth of knowledge and expertise to their roles in the finance industry.